MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $785 | -99.8% | 3,240 | -32.2% | 0.08% | +52.9% |
| Q4 2021 | $405,000 | -44.6% | 4,780 | -47.8% | 0.05% | -31.1% |
| Q3 2021 | $731,000 | +50.1% | 9,156 | +83.0% | 0.07% | +34.5% |
| Q2 2021 | $487,000 | +31.3% | 5,003 | +50.1% | 0.06% | -9.8% |
| Q4 2020 | $371,000 | -66.7% | 3,334 | -72.8% | 0.06% | -53.1% |
| Q4 2019 | $1,115,000 | +251.7% | 12,241 | +232.9% | 0.13% | +202.3% |
| Q3 2019 | $317,000 | -33.4% | 3,677 | +116.0% | 0.04% | +79.2% |
| Q2 2018 | $476,000 | – | 1,702 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |